On March 11th, 2020, the World Health Organization (WHO) declared a pandemic in response to the COVID-19 outbreak.
In response to the surging demand of COVID-19 testing, Amplly Biotech. provides a time-tested solution which is also bio-safe and cost-effective.
CE, CFDA and ISO certified, Anadas is a fully automated and integrated system that can complete molecular tests from specimens to final reports. It is able to complete up to 600 tests within 8 hours and up to 2,000 tests within 24 hours.
The system puts the highest priority on all aspects of biosafety. With the unique design of air pathway and waste control module, it eliminates sample aerosol cross contamination and guarantees the biosafety for the staff, the environment, the device, and the samples. Minimum human handling and lab space are needed, which greatly reduce the overall cost and human error.
More than 500 systems have been installed in CDC labs, major hospitals and test centers.
CE, CFDA and ISO certified, Anadas is a fully automated and integrated system that can complete molecular tests from swabs to final reports.
Amplly’s 3-gene multiplex assay delivers results with high sensitivity and high specificity.